Jordan Reimschisel joins the podcast today to talk about his recent piece in RealClearHealth regarding the FDA and slowing medical innovation. He argues that the process of the FDA is based off a warped incentive structure that places excessive caution ahead of innovation that could save lives.
Last week, the Senate Committee on Health, Education, Labor, and Pensions met to consider legislation that would reauthorize the Food and Drug Administration’s (FDA) user fee programs. These programs make up a large part of the agency’s budget. This process will continue over the next several weeks.
Earlier this month, the House Committee on Energy and Commerce also held a hearing to consider improvements to the regulation of medical technologies. This will most likely become a part of the reauthorization legislation. While an admirable goal, the true goal that policy makers should pursue is to create an environment in which innovation and entrepreneurship can thrive with as few barriers as possible.
Cities and suburbs are getting clobbered by the collapse of the retail sector. But there are ways to use the crisis as a way to speed long-overdue land use reforms.
The proliferation of half-vacant shopping centers and abandoned malls on the fringes of cities has become such a pervasive problem that we have a new word for it: greyfields. Chances are you have a few in your community: acres of paved parking with weeds creeping through the cracks and a dilapidated big-box structure standing in the middle. They’re the increasingly hard-to-ignore manifestation of what’s often described as the retail meltdown. According to the Bureau of Labor Statistics, the retail sector lost approximately 30,000 jobs in March alone, with thousands of store closings projected through 2017. At this pace, store closings in 2017 are likely to surpass the Great Recession year of 2008.